A61M 2202/0417
Immunoglobulin
A61M2202/0417 (Immunoglobulin) appears on 19 US grants and 31 published applications in this corpus.
Search patents in A61M- Granted patents
- 19
- Published applications
- 31
- Assignees
- 29
- Inventors
- 61
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 1 |
| 2012 | 3 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 4 |
| 2023 | 1 | 3 |
| 2024 | 2 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and devices for the enrichment of immunoglobulin from blood30 Jun 2026US 12,668,609 B2Haemonetics Corporation
- Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies3 Dec 2024US 12,156,959 B2Gambro Lundia AB
- Systems and methods for collection of increased volumes of IgG during plasma collection procedures18 Jun 2024US 12,011,530 B2Fenwal, Inc.
- System and method for isolating alpha 2M molecules5 Dec 2023US 11,833,279 B2Astaria Global, LLC
- Immunoadsorption15 Jun 2021US 11,033,639 B2uniQure IP B.V.
- Drug-device combination19 Feb 2026US 2026/0048206 A1PARI Pharma GmbH
- A high performance immunoaffinity based system for extracorporeal capture of pathogens, cancer cells and toxins from blood22 Jan 2026US 2026/0021233 A1CAPTEC Medical Kft.
- System and method for aggregation and autologous use of alpha 2m molecules to treat respiratory conditions30 Jan 2025US 2025/0032683 A1Astaria Global, LLC
- System and method for allogeneic or xenogeneic use of alpha 2m molecules in treating medical conditions23 Jan 2025US 2025/0025610 A1Astaria Global, LLC
- System and method for allogeneic or xenogeneic use of alpha 2m molecules in treating medical conditions20 Jun 2024US 2024/0197969 A1Astaria Global, LLC
Most cited
By later US patents
- Method and compositions for treatments of cancers104US 6,231,536 B12001
- Treatment of aluimmunization and refractoriness to platelet transfusion by protein A column therapy63US 5,277,701 ARegents of the University of Minnesota · 1994
- Method for treatment of rheumatoid arthritis33US 5,782,792 ACypress Bioscience, Inc. · 1998
- Adsorbent composed of porous beads of chitosan and adsorption method using same26US 4,879,340 AKawasumi Kagaku Kougiyou Kabushiki Kaisha · 1989
- Ultra-high yield intravenous immune globulin preparation21US 7,879,332 B2Plasma Technologies, LLC · 2011